Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanoverse Biomaterials is an Indian biotechnology company specializing in the development and commercialization of sustainable novel biomaterials derived from ruminant biowaste using advanced nanotechnology. The company focuses on producing high-quality cellulose nanocrystals, nano fibers, and nano lignin for diverse industrial applications, with a significant emphasis on healthcare solutions such as wound dressings and drug delivery systems. By leveraging its proprietary manufacturing processes, Nanoverse aims to provide biocompatible and biodegradable materials that mimic the human extracellular matrix, facilitating innovations in regenerative medicine. The company is positioned as a leader in the circular economy, transforming agricultural waste into high-value technical materials for the global life sciences market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanoverse.